Trupanion, Inc. filings document the company’s pet medical insurance business, public-company governance, and capital structure. Form 8-K reports include quarterly and annual operating results, with disclosures on subscription revenue, enrolled pets, net acquisition cost, adjusted EBITDA, operating cash flow, and other measures used to describe the company’s insurance economics.
The filing record also covers material agreements, including credit facilities, secured borrowings, maturity terms, covenants, and limits on corporate actions. Proxy materials document director elections, board composition, executive compensation, equity awards, shareholder voting matters, and related governance disclosures.
Trupanion, Inc. (TRUP) CEO Margaret Tooth sold 1,000 common shares for $25.84 per share on October 9, 2026. She held 184,952 common shares directly after the sale. The transaction was made under a Rule 10b5-1(c) trading plan adopted May 11, 2026; the footnote states she had no discretion over its timing.
Trupanion, Inc. is the issuer named in Margaret R. Tooth’s notice of a proposed sale of 1,000 common shares, with an aggregate market value of $25,840 and an approximate sale date of October 9, 2026. The notice lists Morgan Stanley Smith Barney LLC as the broker. The shares are identified as restricted stock acquired from the issuer on February 25, 2022.
Trupanion, Inc. (TRUP) Chief Operating Officer John R. Gallagher reported a sale of 431 common shares at $22.92 per share on September 28, 2026. He reported 33,311 shares following the transaction. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted August 20, 2025, for financial diversification; the footnote states that Gallagher had no discretion over the transaction’s timing.
Trupanion, Inc. officer John Gallagher reported a proposed sale of 431 common shares, with an aggregate market value of $9,878.52; September 28, 2026 is listed as the sale date, and NASDAQ as the exchange. The shares were acquired upon vesting of restricted stock during November 25, 2023, through February 25, 2024. His listed prior sales were 3,604 shares, reported at $107,038.80, on August 28, 2026; 431 shares, reported at $10,809.48, on July 28, 2026; and 431 shares, reported at $10,925.85, on June 29, 2026.
TRUPANION, INC. (TRUP) director and CEO Margaret Tooth reported selling 1,000 shares of common stock on September 11, 2026 at $25.00 per share in an open-market or private transaction. After this sale, she directly holds 185,952 shares. The transaction occurred under a Rule 10b5-1 trading plan adopted on May 11, 2026.
TRUPANION, INC. (TRUP) is the issuer for a planned resale of shares by security holder Margaret R. Tooth under Rule 144. The notice covers 1,000 shares of common stock, with an indicated aggregate market value of $25,000.00, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ around September 11, 2026.
The shares were acquired as restricted stock from the issuer on February 25, 2022, and the filing also notes a prior sale of 978 shares during the past three months for proceeds of $28,410.90.
TRUPANION, INC. (TRUP) reported that Chief Operating Officer John R. Gallagher sold 3,604 shares of common stock on August 28, 2026 at $29.70 per share in an open-market or private transaction. Following the sale, he directly holds 33,742 shares. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, under which he had no discretion over timing.
TRUPANION, INC. (TRUP) had a notice filed under Rule 144 by officer John Ross Gallagher for a planned sale of its common stock. The notice covers 3,604 shares of common stock, held at Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $107,038.80 and reference to 43,872,611 shares outstanding as context. The securities to be sold were acquired upon the vesting of restricted stock during the period from 11/25/2023 through 08/22/2026. Gallagher also reports prior sales over the past three months of 431 shares on each of 06/29/2026 and 07/28/2026, for proceeds of $10,925.85 and $10,809.48, respectively.
TRUPANION, INC. (TRUP) director Howard E. Rubin reported equity-compensation activity involving restricted stock units and common stock. On August 22, 2026, three blocks of 140 RSUs each, covering 140 shares of common stock per block, were reported as derivative dispositions, while corresponding three acquisitions of 140 common shares each were reported as exercises/conversions. Footnotes state the RSUs convert into common stock on a one-for-one basis and vest in quarterly installments through May 22, 2027, in connection with Rubin’s service on boards of wholly owned subsidiaries.
TRUPANION, INC. (TRUP) director Bradley S. Powell reported the vesting and conversion of 1,640 Restricted Stock Units into common stock on a one-for-one basis. This RSU conversion resulted in an acquisition of 1,640 shares of common stock, bringing his directly held common stock to 3,546 shares, with 4,923 RSUs remaining outstanding that continue to vest through May 22, 2027, subject to continued service.